Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11299532 Anti-VEGF protein compositions and methods for producing the same

Patent 11299532 was granted and assigned to Regeneron Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions in chemically defined media to reduce amounts of certain Aflibercept variants.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11299532 Anti-VEGF protein compositions and methods for producing the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo